Presenter's Information
David R. Holmes, MD
Country | USA |
Specialty | Interventional Cardiologist |
- Moderators\' Introductory Keynote: Why This Debate So Controversial?
- Overtreatment in Cardiology in 2018! What Is Reasonable?
- PCI vs. CABG for Left Main in 2018 - Expert\'s View on U.S. Future Guideline Change
- WATCHMAN: Data Synthesis and Ongoing Trials
- [Special Lecture] Stroke Prevention in Non-Valvular Atrial Fibrillation
- Future Perspective on LM Revascularization: From Evidence to Real Practice
- Bioprosthetic Valve Thrombosis(TAVR & SAVR)
- LAA Occlusion for Stroke Prevention: What Is the Ideal?
- TAVI for Combined CAD
- How Should LAA Closure Devices Be Integrated into Clinical Practice?
- Practical Experience: Longterm Results and Obstacles
- Guideline Today: Focus on the Culprit!
- Update on TAVR Results 2014
- Left Atrial Appendage Closure: Clinical Data and Future Perspective
- Left Atrial Appendage Occlusion: Results and Future Predictions
- Update on LAA Closure Devices: Will They Get Approved?
- Update on PROTECT AF
- Viable Role in ACS or PCI Patients: Combination of Anticoagulant and Antiplatelet Is Still Attractive Approach.
- STICH: Physician\'s Perspective
- The SYNTAX Message Is Clear: CABG Is Preferred in Complex Multivessel Disease
- Differential Treatment Effects of PCI vs. CABG in Diabetic and Non-Diabetic Patients
- Coronary Intervention
- Revascularization Strategies (SYNTAX, BARI-2D, and STICH)
- Revascularization in Diabetes: New Insights from the BARI 2D
- Timing of Angiography after NSTEMI. Now, or a Little Later, or Only If Needed?
- No More Routine Surgery!
- PROTECT AF Trial: Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF
- [Debate] Which one Is the Best Choice in Left Main Revascularization?: : PCI Is the Best Choice.
- In-Stent Restenosis: The Last Achilles' Hill to Still Conquer
- Do DES Increase or Decrease Mortality for "On-Label" and "Off-Label" Use Indications?
- DES Thrombosis: Is It Real and Is It Worse? New Approaches to Solving It ?
- The Preponderance of Data Favors CYPHER!
- SISR. A Prospective Randomized Comparison of the Sirolimus-Eluting Stent vs Brachytherapy in Patients with Bare Metal In-Stent Restenosis
- THE GREAT DEBATE : All Patients Should Receive a Drug Eluting Stent - CON